Stocks Swings: Portola Pharmaceuticals, Inc. (NASDAQ:PTLA), Live Ventures Incorporated (NASDAQ:LIVE), Karyopharm Therapeutics, Inc. (NASDAQ:KPTI), Limelight Networks, Inc.

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) provided a corporate update and reported its financial results for the fourth quarter and year ended December 31, 2015. Collaboration revenue earned under Portola’s collaborations with Bristol-Myers Squibb Company and Pfizer, Bayer Pharma and Janssen Pharmaceuticals, Daiichi Sankyo and Lee’s Pharmaceutical was $4.4 million for the fourth quarter of 2015 compared with $2.4 million for the fourth quarter of 2014. Collaboration revenue for the year ended December 31, 2015, was $12.1 million compared with $9.6 million for the year ended December 31, 2014.

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) belongs to Healthcare sector. Its weekly performance is -6.43%. On last trading day company shares ended up at $27.79. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) distance from 50-day simple moving average (SMA50) is -0.72%.

On 16 February, Live Ventures Incorporated (NASDAQ:LIVE) announces financial results from its fiscal first quarter, which ended December 31, 2015. The company’s revenues increased 151% to $20.1 million, compared to $8.0 million over the same period one year ago. Gross profit was up 98% to $6.4 million. Earnings were $0.01 per share. Earnings before interest, taxes, depreciation and amortization (EBITDA) were $1.6 million, or $0.09 per share. Cash flow from operations were $2.7 million.

Live Ventures Incorporated (NASDAQ:LIVE) shares advanced 14.01% in last trading session and ended the day at $1.52. LIVE Gross Margin is 31.90% and its return on assets is -34.30%. Live Ventures Incorporated (NASDAQ:LIVE) quarterly performance is 4.83%.

Karyopharm Therapeutics Inc (NASDAQ:KPTI) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Tuesday, MarketBeat reports.

On 26 February, Karyopharm Therapeutics, Inc. (NASDAQ:KPTI) shares advanced 5.00% and was closed at $6.09. Karyopharm Therapeutics, Inc. (NASDAQ:KPTI) year to date (YTD) performance is -54.04%.

On 9 February, Limelight Networks, Inc. (NASDAQ:LLNW) reported a net loss of $4.145 million, or 4 cents per share, on revenue of $42.7 million for the quarter ended Dec. 31. This compares to a net loss of $5 million, or a loss of 5 cents per share, on revenue of $40.7 million for the same quarter a year ago.

Limelight Networks, Inc. (NASDAQ:LLNW) ended the last trading day at $1.47. Company weekly volatility is calculated as 7.38% and price to cash ratio as 9.88. Limelight Networks, Inc. (NASDAQ:LLNW) showed a weekly performance of 20.49%.

On 24 February, Green Dot Corporation (NYSE:GDOT) projects an annual profit of $1.35 to $1.40 a share, on $700 million to $705 million in revenue. Analysts surveyed by Thomson Reuters projected $1.34 a share on $701.7 million in revenue.

Green Dot Corporation (NYSE:GDOT) shares advanced 0.82% in last trading session and ended the day at $20.87. GDOT return on assets is 5.10%. Green Dot Corporation (NYSE:GDOT) quarterly performance is 25.12%.

Leave a Reply

Your email address will not be published. Required fields are marked *